![Gina Chapman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/07/2026
Gina Chapman currently works at Entrada Therapeutics, Inc., as Independent Director from 2023 and Verizon Capital Corp., as Manager.
Ms. Chapman also formerly worked at Cargo Therapeutics, Inc., as President, Chief Executive Officer & Director from 2022 to 2025 and Roche Group, as Senior Vice President-Business Unit Head from 2021 to 2022.
Ms. Chapman received her undergraduate degree from the University of California, Santa Barbara.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/09/2023 |
Verizon Capital Corp.
 Verizon Capital Corp. Finance/Rental/LeasingFinance Provides equipment rental and lease financing | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| CARO THERPAR | Director Ejecutivo | 18/03/2025 |
Roche Group
 Roche Group Real Estate DevelopmentFinance Manages real estate properties | Corporate Officer/Principal | 01/04/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Verizon Capital Corp.
Verizon Capital Corp. Finance/Rental/LeasingFinance Provides equipment rental and lease financing | Finance |
Roche Group
Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entrada Therapeutics, Inc.
 Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
Cargo Therapeutics, Inc.
 Cargo Therapeutics, Inc. BiotechnologyHealth Technology Engages in generation of adoptive cell therapies for cancer treatment | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
